120 related articles for article (PubMed ID: 32686932)
1. Construction of Ginsenoside Nanoparticles with pH/Reduction Dual Response for Enhancement of Their Cytotoxicity Toward HepG2 Cells.
Xu Y; Li X; Gong W; Huang HB; Zhu BW; Hu JN
J Agric Food Chem; 2020 Aug; 68(32):8545-8556. PubMed ID: 32686932
[TBL] [Abstract][Full Text] [Related]
2. Glycogen-based pH and redox sensitive nanoparticles with ginsenoside Rh
Xu Y; Zhu BW; Li X; Li YF; Ye XM; Hu JN
Biomaterials; 2022 Jan; 280():121077. PubMed ID: 34890974
[TBL] [Abstract][Full Text] [Related]
3. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
[TBL] [Abstract][Full Text] [Related]
4. Colon-Targeting
Xu Y; Zhu BW; Sun R; Li X; Wu D; Hu JN
ACS Appl Mater Interfaces; 2023 Jun; 15(22):26298-26315. PubMed ID: 37233992
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
[TBL] [Abstract][Full Text] [Related]
6. Novel multicore niosomes based on double pH-sensitive mixed micelles for Ginsenoside Rh2 delivery.
Chen D; Yu H; Mu H; Li G; Shen Y
Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):205-9. PubMed ID: 24823243
[TBL] [Abstract][Full Text] [Related]
7. Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
Mathiyalagan R; Wang C; Kim YJ; Castro-Aceituno V; Ahn S; Subramaniyam S; Simu SY; Jiménez-Pérez ZE; Yang DC; Jung SK
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795352
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside compound K-bearing glycol chitosan conjugates: synthesis, physicochemical characterization, and in vitro biological studies.
Mathiyalagan R; Subramaniyam S; Kim YJ; Kim YC; Yang DC
Carbohydr Polym; 2014 Nov; 112():359-66. PubMed ID: 25129755
[TBL] [Abstract][Full Text] [Related]
9. Esterification of Ginsenoside Rh2 Enhanced Its Cellular Uptake and Antitumor Activity in Human HepG2 Cells.
Chen F; Deng ZY; Zhang B; Xiong ZX; Zheng SL; Tan CL; Hu JN
J Agric Food Chem; 2016 Jan; 64(1):253-61. PubMed ID: 26672619
[TBL] [Abstract][Full Text] [Related]
10. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
11. The Octyl Ester of Ginsenoside Rh2 Induces Lysosomal Membrane Permeabilization via Bax Translocation.
Chen F; Zhang B; Sun Y; Xiong ZX; Peng H; Deng ZY; Hu JN
Nutrients; 2016 Apr; 8(5):. PubMed ID: 27120618
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rh2 reverses sleep deprivation-induced cognitive deficit in mice.
Lu C; Wang Y; Lv J; Jiang N; Fan B; Qu L; Li Y; Chen S; Wang F; Liu X
Behav Brain Res; 2018 Sep; 349():109-115. PubMed ID: 29544964
[TBL] [Abstract][Full Text] [Related]
13. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
14. Production of the Rare Ginsenoside Rh2-MIX (20(
Song BK; Kim KM; Choi KD; Im WT
J Microbiol Biotechnol; 2017 Jul; 27(7):1233-1241. PubMed ID: 28478658
[TBL] [Abstract][Full Text] [Related]
15. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X
Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147
[TBL] [Abstract][Full Text] [Related]
16. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
[TBL] [Abstract][Full Text] [Related]
17. Stereoisomer-specific anticancer activities of ginsenoside Rg3 and Rh2 in HepG2 cells: disparity in cytotoxicity and autophagy-inducing effects due to 20(S)-epimers.
Cheong JH; Kim H; Hong MJ; Yang MH; Kim JW; Yoo H; Yang H; Park JH; Sung SH; Kim HP; Kim J
Biol Pharm Bull; 2015; 38(1):102-8. PubMed ID: 25744465
[TBL] [Abstract][Full Text] [Related]
18. Preparation of pH-sensitive carboxymethyl chitosan nanoparticles loaded with ginsenoside Rb1 and evaluation of drug release in vitro.
An Z; Dong Y; Wang W; Wang J; Wu Z; Wang W; He Y; Bao G
Int J Biol Macromol; 2024 May; 267(Pt 2):131487. PubMed ID: 38599430
[TBL] [Abstract][Full Text] [Related]
19. Tumor pH(e)-triggered charge-reversal and redox-responsive nanoparticles for docetaxel delivery in hepatocellular carcinoma treatment.
Chen F; Zhang J; Wang L; Wang Y; Chen M
Nanoscale; 2015 Oct; 7(38):15763-79. PubMed ID: 26355843
[TBL] [Abstract][Full Text] [Related]
20. A ROS-mediated lysosomal-mitochondrial pathway is induced by ginsenoside Rh2 in hepatoma HepG2 cells.
Chen F; Deng Z; Xiong Z; Zhang B; Yang J; Hu J
Food Funct; 2015 Dec; 6(12):3828-37. PubMed ID: 26449932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
